HEADER TOXIN 28-DEC-20 7L7A TITLE SOLUTION STRUCTURE OF NUXVA COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUXVA; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CONUS NUX; SOURCE 3 ORGANISM_TAXID: 101310 KEYWDS CONOTOXIN, MALARIA, BIOPLEX ASSAY, PROTEOGENOMICS, ERYTHROCYTE KEYWDS 2 MEMBRANE PROTEIN 1, TOXIN EXPDTA SOLUTION NMR NUMMDL 32 AUTHOR F.MARI,S.DOVELL REVDAT 3 14-JUN-23 7L7A 1 REMARK REVDAT 2 03-FEB-21 7L7A 1 JRNL REVDAT 1 13-JAN-21 7L7A 0 JRNL AUTH A.PADILLA,S.DOVELL,O.CHESNOKOV,M.HOGGARD,A.V.OLEINIKOV, JRNL AUTH 2 F.MARI JRNL TITL CONUS VENOM FRACTIONS INHIBIT THE ADHESION OF PLASMODIUM JRNL TITL 2 FALCIPARUM ERYTHROCYTE MEMBRANE PROTEIN 1 DOMAINS TO THE JRNL TITL 3 HOST VASCULAR RECEPTORS. JRNL REF J PROTEOMICS V. 234 04083 2020 JRNL REFN ISSN 1876-7737 JRNL PMID 33373718 JRNL DOI 10.1016/J.JPROT.2020.104083 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TORSION ANGLE DYNAMICS REMARK 4 REMARK 4 7L7A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253727. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : LOW-MEDIUM REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.275 MM NUXVA, 10 % [U-99% 2H] REMARK 210 D2O, 0.025 MM TSP, 90 % H2O, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 1D 1H EXCHANGE REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR, X-PLOR NIH 2.21, NMRFAM REMARK 210 -SPARKY, AQUA, PROCHECK / REMARK 210 PROCHECK-NMR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 32 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 2 -144.15 -75.88 REMARK 500 1 THR A 8 151.11 -45.64 REMARK 500 1 VAL A 12 98.06 26.65 REMARK 500 1 ILE A 13 48.39 -87.69 REMARK 500 2 VAL A 12 101.65 -15.20 REMARK 500 3 CYS A 3 -172.42 -66.72 REMARK 500 3 THR A 8 167.36 -44.98 REMARK 500 3 VAL A 12 96.48 19.89 REMARK 500 4 CYS A 2 -75.59 -56.93 REMARK 500 4 THR A 8 165.91 -45.06 REMARK 500 4 VAL A 12 75.75 19.13 REMARK 500 5 THR A 8 167.26 -45.31 REMARK 500 5 VAL A 12 89.04 24.11 REMARK 500 6 CYS A 3 -171.84 -64.93 REMARK 500 6 THR A 8 155.63 -40.36 REMARK 500 6 VAL A 12 89.00 24.02 REMARK 500 7 CYS A 2 -72.04 -74.57 REMARK 500 7 THR A 8 171.42 -59.68 REMARK 500 7 VAL A 12 94.03 -11.72 REMARK 500 8 THR A 8 171.98 -52.73 REMARK 500 8 VAL A 12 93.11 -1.01 REMARK 500 9 CYS A 2 -78.67 -81.60 REMARK 500 9 CYS A 3 -177.62 -63.21 REMARK 500 9 THR A 8 163.56 -43.76 REMARK 500 9 VAL A 12 92.21 -20.61 REMARK 500 10 THR A 8 156.22 -43.47 REMARK 500 10 VAL A 12 94.41 22.70 REMARK 500 10 ILE A 13 40.29 -88.85 REMARK 500 11 CYS A 3 170.48 -55.95 REMARK 500 11 THR A 8 174.53 -59.55 REMARK 500 11 VAL A 12 97.88 -16.28 REMARK 500 12 LEU A 7 -165.71 -122.83 REMARK 500 12 VAL A 12 84.08 3.08 REMARK 500 13 CYS A 2 -107.37 -89.43 REMARK 500 13 LEU A 7 -153.03 -139.04 REMARK 500 13 VAL A 12 91.68 14.92 REMARK 500 14 CYS A 2 -74.61 -89.03 REMARK 500 14 THR A 8 159.09 -37.86 REMARK 500 14 VAL A 12 83.67 12.44 REMARK 500 15 CYS A 2 -131.67 -69.86 REMARK 500 15 THR A 8 159.00 -43.77 REMARK 500 15 VAL A 12 96.48 22.91 REMARK 500 16 THR A 8 170.89 -54.07 REMARK 500 16 VAL A 12 99.89 -18.28 REMARK 500 17 CYS A 2 -83.10 -76.03 REMARK 500 17 THR A 8 157.00 -44.33 REMARK 500 17 VAL A 12 82.71 24.11 REMARK 500 18 CYS A 2 -71.68 -79.85 REMARK 500 18 THR A 8 156.74 -42.32 REMARK 500 18 VAL A 12 88.51 22.85 REMARK 500 REMARK 500 THIS ENTRY HAS 88 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30833 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF NUXVA DBREF 7L7A A 1 14 PDB 7L7A 7L7A 1 14 SEQRES 1 A 14 GLY CYS CYS PRO ALA PRO LEU THR CYS HIS CYS VAL ILE SEQRES 2 A 14 TYR SSBOND 1 CYS A 2 CYS A 9 1555 1555 2.02 SSBOND 2 CYS A 3 CYS A 11 1555 1555 2.03 CISPEP 1 ALA A 5 PRO A 6 1 0.15 CISPEP 2 ALA A 5 PRO A 6 2 -0.04 CISPEP 3 ALA A 5 PRO A 6 3 0.32 CISPEP 4 ALA A 5 PRO A 6 4 0.36 CISPEP 5 ALA A 5 PRO A 6 5 0.60 CISPEP 6 ALA A 5 PRO A 6 6 -0.18 CISPEP 7 ALA A 5 PRO A 6 7 0.41 CISPEP 8 ALA A 5 PRO A 6 8 0.69 CISPEP 9 ALA A 5 PRO A 6 9 -0.28 CISPEP 10 ALA A 5 PRO A 6 10 0.27 CISPEP 11 ALA A 5 PRO A 6 11 0.34 CISPEP 12 ALA A 5 PRO A 6 12 0.10 CISPEP 13 ALA A 5 PRO A 6 13 0.50 CISPEP 14 ALA A 5 PRO A 6 14 0.10 CISPEP 15 ALA A 5 PRO A 6 15 -0.23 CISPEP 16 ALA A 5 PRO A 6 16 0.33 CISPEP 17 ALA A 5 PRO A 6 17 0.33 CISPEP 18 ALA A 5 PRO A 6 18 0.05 CISPEP 19 ALA A 5 PRO A 6 19 0.53 CISPEP 20 ALA A 5 PRO A 6 20 0.05 CISPEP 21 ALA A 5 PRO A 6 21 0.29 CISPEP 22 ALA A 5 PRO A 6 22 -0.03 CISPEP 23 ALA A 5 PRO A 6 23 0.58 CISPEP 24 ALA A 5 PRO A 6 24 0.57 CISPEP 25 ALA A 5 PRO A 6 25 0.65 CISPEP 26 ALA A 5 PRO A 6 26 0.23 CISPEP 27 ALA A 5 PRO A 6 27 -0.06 CISPEP 28 ALA A 5 PRO A 6 28 0.51 CISPEP 29 ALA A 5 PRO A 6 29 0.12 CISPEP 30 ALA A 5 PRO A 6 30 0.24 CISPEP 31 ALA A 5 PRO A 6 31 0.46 CISPEP 32 ALA A 5 PRO A 6 32 0.38 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1